Lupus-like syndrome induced by procainamide.
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001323:Autoantibodies / Q000032:analysis*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D011342:Procainamide